Innospec Inc. (NASDAQ:IOSP – Get Free Report) Director Larry Padfield sold 1,030 shares of the company’s stock in a transaction on Friday, February 20th. The stock was sold at an average price of $81.84, for a total value of $84,295.20. Following the sale, the director owned 8,508 shares of the company’s stock, valued at approximately $696,294.72. This represents a 10.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
Innospec Stock Performance
IOSP stock opened at $78.15 on Thursday. The company has a market capitalization of $1.94 billion, a P/E ratio of 16.70, a PEG ratio of 2.09 and a beta of 0.91. The company has a fifty day moving average price of $81.18 and a 200-day moving average price of $79.28. Innospec Inc. has a 52-week low of $70.10 and a 52-week high of $105.39.
Innospec (NASDAQ:IOSP – Get Free Report) last announced its quarterly earnings data on Tuesday, February 17th. The specialty chemicals company reported $1.50 EPS for the quarter, topping the consensus estimate of $1.26 by $0.24. The company had revenue of $455.60 million during the quarter, compared to the consensus estimate of $460.87 million. Innospec had a net margin of 6.56% and a return on equity of 10.18%. The company’s quarterly revenue was down 2.4% on a year-over-year basis. During the same quarter last year, the firm posted $1.41 EPS. As a group, sell-side analysts forecast that Innospec Inc. will post 6.18 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Innospec
Wall Street Analyst Weigh In
A number of brokerages have weighed in on IOSP. Zacks Research lowered shares of Innospec from a “hold” rating to a “strong sell” rating in a research report on Thursday, February 19th. Weiss Ratings upgraded Innospec from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, February 19th. Finally, Wall Street Zen upgraded Innospec from a “hold” rating to a “buy” rating in a research report on Saturday, December 13th. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Reduce”.
Read Our Latest Stock Analysis on Innospec
Innospec Company Profile
Innospec Incorporated (NASDAQ: IOSP) is a global specialty chemicals company headquartered in Cleveland, Ohio. The company operates through three principal business segments: Fuel Specialties, Oilfield Services, and Performance Chemicals. In the Fuel Specialties segment, Innospec develops and supplies additives designed to enhance octane levels, improve combustion efficiency, reduce emissions and prevent deposit formation in gasoline and diesel engines. Its Oilfield Services division provides chemical technologies—such as surfactants, corrosion inhibitors and demulsifiers—to support exploration, drilling, production optimization and enhanced oil recovery operations.
Featured Articles
- Five stocks we like better than Innospec
- MAJOR BUY ALERT: Mar-a-Lago/Trump/Elon
- REVEALED: Something Big Happening Behind White House Doors
- ALERT: Drop these 5 stocks before the market opens tomorrow!
- Why the Smart Money Is Looking Beyond Single-Metal Stories
- Read this or regret it forever
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.
